Physician profile
David Jason Mccracken
NPI 1881983492
$425,296.03
in general payments reported to CMS, 2019-2025
25 companies · $154K in 2025
The $154K reported for 2025 was more than what 98% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,073 · 2020: $10K · 2021: $19K · 2022: $50K · 2023: $98K · 2024: $91K · 2025: $154K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $297K · Travel and Lodging: $24K · Honoraria: $16K · Food and Beverage: $6,500 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $296,803.73 |
| Travel and Lodging | $23,777.75 |
| Honoraria | $15,750.00 |
| Food and Beverage | $6,500.45 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,095.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $372,055.20 | 2019-2025 | Gammatile, Gammatile |
| Stryker Corporation | $41,032.66 | 2019-2025 | Spetzler-Malis, Mako, Core |
| Nx Development Corp. | $9,717.35 | 2019-2020 | |
| Medtronic, INC. | $1,325.70 | 2025 | Visualase |
| Novocure INC. | $289.74 | 2020-2022 | |
| Brainlab, INC. | $90.55 | 2021-2022 | |
| Longeviti Neuro Solutions INC | $90.36 | 2025 | Clearfit |
| Depuy Synthes Sales INC. | $88.39 | 2019-2023 | Synthecel |
| Integra Lifesciences Corporation | $77.92 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $71.62 | 2019 | |
| Arbor Pharmaceuticals, INC. | $60.88 | 2019-2021 | |
| Olympus America INC. | $50.90 | 2020 | |
| Medexus Pharma, INC. | $49.83 | 2022 | |
| Alexion Pharmaceuticals, INC. | $43.52 | 2021-2022 | |
| Spineology INC. | $42.31 | 2023 | Optimesh Expandable Interbody Fusion System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $28.66 | 2021-2022 | |
| Coherus Oncology, INC. | $28.45 | 2020 | |
| Globus Medical, INC. | $26.42 | 2023 | Excelsiusgps Robotic Navigation System |
| Astrazeneca Pharmaceuticals Lp | $23.78 | 2024 | Andexxa |
| Bayer Healthcare Pharmaceuticals INC. | $23.68 | 2020 | |
| Neurelis, INC. | $22.77 | 2022 | |
| Sunovion Pharmaceuticals INC. | $20.84 | 2020 | |
| Irras USA, INC. | $15.61 | 2020 | |
| Kyowa Kirin, INC. | $11.89 | 2019 | |
| Omniscient Neurotechnology America Ltd | $7.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mccracken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.